Quantcast

Latest Vernakalant Stories

2014-08-25 16:25:45

NASDAQ: CRME TSX: COM VANCOUVER, Aug. 25, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that its subsidiary, Correvio International Sàrl, has entered into an agreement with Eurolab Especialidades Medicinales de Eurofar S.R.L. to sell and distribute BRINAVESS(TM) (vernakalant intravenous) exclusively in Argentina. Under the terms of the agreement, Eurolab has agreed to specific annual commercial goals for BRINAVESS(TM). Financial details...

2014-08-06 12:29:32

NASDAQ: CRME TSX: COM VANCOUVER, Aug. 6, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that William Hunter, M.D., President & CEO of Cardiome, will present an update on the company's progress at the Canaccord Genuity Growth Conference on August 13, 2014 at 2:00 p.m. EDT in Boston. A live webcast and a replay of the company's presentation will be available on the Cardiome corporate website at www.cardiome.com. About Cardiome Pharma...

2014-08-05 16:27:18

NASDAQ: CRME TSX: COM VANCOUVER, Aug. 5, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced submission of the BRINAVESS(TM) reimbursement dossier to Belgium's national compulsory health care and benefits insurance authority, The National Institute for Health and Disability Insurance (Institut National d'Assurance Maladie Invalidité or INAMI). "We are pleased to have submitted the application for BRINAVESS reimbursement and potentially could...

2014-08-05 12:32:08

NASDAQ: CRME, TSX: COM VANCOUVER, Aug. 5, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report financial results for the second quarter ended June 30, 2014 on the morning of Monday, August 11, 2014. Cardiome will hold a conference call and webcast at 8:00 a.m. Eastern (5:00 a.m. Pacific) on that day to discuss the results. To access the conference call, please dial 416-764-8688 or 888-390-0546 and use conference ID 04422550. The...

2014-07-18 16:23:26

NASDAQ: CRME, TSX: COM VANCOUVER, July 18, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced today the closing of a senior, secured term loan facility of up to $22 million to be made available to the company by MidCap Financial, LLC in two tranches with an interest rate of Libor plus 8%. Cardiome currently intends to use the proceeds of the first tranche of $12 million for working capital and general corporate purposes, including the expansion of its sales and...

2014-06-17 08:28:59

NASDAQ: CRME TSX: COM VANCOUVER, June 17, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the results of voting at its 2014 Annual General and Special Meeting of Shareholders held on June 16, 2014. A total of 3,891,837 common shares were voted in connection with the meeting, representing approximately 23.56% of the issued and outstanding common shares of the company. Shareholders voted as follows: Appointment of Auditor By resolution passed by...

2014-06-11 08:28:58

NASDAQ: CRME TSX: COM VANCOUVER, June 11, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME) (TSX: COM) today announced that William Hunter, M.D., President & CEO of Cardiome, will present an update on the company's progress at the Bloom Burton & Co. Healthcare Investor Conference at the Toronto Board of Trade on June 18, 2014 in Toronto. Cardiome's corporate presentation will be available on the company website at www.cardiome.com following Dr. Hunter's...

2014-06-10 08:30:11

NASDAQ: CRME TSX: COM VANCOUVER, June 10, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that pursuant to the increase in size of the Board of Directors to six members, as disclosed in the 2014 information circular, an additional director nominee will be included at its 2014 Annual General and Special Meeting of Shareholders held on June 16, 2014. The Company is pleased to announce the nomination of W. James O'Shea to the Board of...

2014-05-20 08:31:56

NASDAQ: CRME TSX: COM VANCOUVER, May 20, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME) (TSX: COM) today announced an agreement with AOP Orphan Pharmaceuticals AG, headquartered in Vienna, Austria, to commercialize AGGRASTAT(®) (tirofiban HCl) in selected European markets. AOP Orphan will be responsible for the commercialization of AGGRASTAT in the AOP Orphan countries. Under terms of the agreement, AOP Orphan has agreed to specific annual commercial goals for...

2014-05-12 16:29:21

Cardiome to conduct conference call and webcast today, May 12, at 5:00 p.m. Eastern (2:00 p.m. Pacific)NASDAQ: CRME TSX: COM VANCOUVER, May 12, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the first quarter ended March 31, 2014. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP). All share and per...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related